Who Pays for the Time You Just Saved?
The second half of The Autonomy Line: when automation hands back hours, who ends up holding them.
Did the Patient Get the Drug Any Sooner?
The first half of The Autonomy Line: the one question that tells you whether an AI rollout worked.
The Buyer's Guide.
How to choose a hub partner in the forced-transition window — three pillars, five red flags, one pricing model.
The cost of disconnection.
How fragmented hubs quietly tax every stakeholder.
Inside the specialty pharmacy patient experience.
Why the forced-transition moment is the best hub hiring window in twenty years.
The AI Readiness Continuum — full reveal.
The whole framework in one place: three areas, one continuum, and why readiness reads from the weakest one.
Healthcare enterprise architecture is already obsolete.
Why the governance and accountability questions are actually an architecture question.
The Framework Trap.
Why every healthcare AI rollout is measuring the wrong thing.
The Readiness Illusion.
High adoption scores can coexist with an organization that is not ready for the first AI decision that goes wrong.
What regulators are coming for — and how governance protects you.
The gap between documented policy and actual workflow is where the liability lives.
Automation bias is the real risk nobody is talking about.
The danger isn't AI errors. It's what happens when AI is mostly right and people stop looking.
Before the newsletter — and beside it.
Essays, field notes, and episode companions published on Substack. Same practice, different shelf.
UnitedHealth is spending $1.5B on AI — what should everyone else do?
The three-layer architecture and the $200K playbook, with Versatad's Rob Tinsley and Jason St. Peter.
2 ledgers, 1 patient — why the payer seam stays open.
How the gap between the admin P&L and the medical-loss ratio makes prior-auth “savings” reappear as downstream care cost.
Why activity-pricing built the tax.
How a per-case contract structure quietly converts every touchpoint into billable friction — the full argument.
The $500B drug access problem — AI can't solve it.
Access friction isn't a model problem. It's an incentive and architecture problem wearing an AI costume.
The dashboard says your AI rollout is on track. Your nurse case manager is drafting her exit.
Adoption metrics can be green while the people carrying the change are quietly leaving.
Disconnected care. Connected fix.
The three-layer architecture that makes AI work in HUB operations.
Your rating reflects their ceiling. Not your worth.
On performance reviews, self-worth, and the careers that outgrow the systems measuring them.
Nine systems. Zero shared identity. One patient.
Disconnected care isn't inevitable. It's an architecture choice — and the version of AI failure no one talks about.
The gate vs. the guardrail.
The goal isn't less oversight. It's smarter oversight — calibrated to risk, not defaulted to fear.
The handoff problem in specialty pharma hubs.
"Human-in-the-loop" without workflow specificity is a gap wearing the vocabulary of a framework.
Stop mapping workflows. Start mapping data.
These aren't implementation failures. They're sequencing failures.